Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

METHIMAZOLE: ABSORPTION, METABOLISM AND EXCRETION IN THE ALBINO RAT

D. S. SITAR and D. P. THORNHILL
Journal of Pharmacology and Experimental Therapeutics February 1973, 184 (2) 432-439;
D. S. SITAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. P. THORNHILL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Methimazole-2-14C was administered to Sprague-Dawley rats, of either sex, i.v., i.p. or p.o. at a dose of 20 mg/kg. The drug was completely absorbed after oral administration. Equilibrium dialysis indicated that 5% of the drug was bound to plasma proteins. The drug was not found to have an affinity for any particular tissue. Methimazole was found to have a much greater chloroform/water partition coefficient and water solubility than propylthiouracil. Between 77 and 95% of the administered radioactivity was excreted into the urine and approximately 10% appeared in the bile. Since negligible radioactivity was excreted into the feces, an enterohepatic circulation was present. The half-life of urinary excretion of radioactivity was five to seven hours regardless of the route of administration. Fourteen to 21% of the administered dose was excreted unchanged in the 24-hour urine. The major urinary metabolite was methimazole glucuronide, which accounted for 36 to 48% of the administered dose in 24-hour urine samples. The only other urinary metabolite, which accounted for 10 to 20% of the dose in 24 hours, has not yet been characterized. The major biliary metabolite was determined to be methimazole glucuronide and was identical to the glucuronide conjugate found in urine samples. Two other unidentified metabolites appeared in the bile, one of which is identical to the unidentified urinary metabolite.

Footnotes

    • Received August 23, 1971.
    • Accepted October 10, 1972.
  • © 1973 by The Williams & Wilkins Co.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 184, Issue 2
1 Feb 1973
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
METHIMAZOLE: ABSORPTION, METABOLISM AND EXCRETION IN THE ALBINO RAT
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

METHIMAZOLE: ABSORPTION, METABOLISM AND EXCRETION IN THE ALBINO RAT

D. S. SITAR and D. P. THORNHILL
Journal of Pharmacology and Experimental Therapeutics February 1, 1973, 184 (2) 432-439;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

METHIMAZOLE: ABSORPTION, METABOLISM AND EXCRETION IN THE ALBINO RAT

D. S. SITAR and D. P. THORNHILL
Journal of Pharmacology and Experimental Therapeutics February 1, 1973, 184 (2) 432-439;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Ethnic Differences in N-Glucuronidation of Nicotine and Cotinine
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics